Products
B2B Zone
3rd Viral Vector Process Development and Manufacturing Summit
3rd Viral Vector Process Development and Manufacturing Summit
Conferences

3rd Viral Vector Process Development and Manufacturing Summit

By

Hanson Wade

2 Followers
19 Feb 2025 - 21 Feb 2025
Free Registration

Event Details

3rd Viral Vector Process Development and Manufacturing Summit

The 3rd Viral Vector Process Development and Manufacturing Summit

Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More

The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders from the likes of Sanofi, Kite, Ultragenyx, Sangamo, UCB, and more to focus on advancing the production of viral vectors for cell and gene therapeutics.

2024 has been pivotal for viral vector manufacturing, with more gene therapies in market and regulatory frameworks evolving to support scalable production. With 800+ gene therapy candidates in clinical trials, the focus is on optimizing processes to reduce costs and improve consistency.

Don't miss the only summit dedicated to viral vector process development and manufacturing, featuring talks, panels, roundtables, and 2 interactive workshops. Gain valuable insights into the regulatory landscape and data-driven presentations across upstream and downstream process development on key topics such as:
- Elevating Yield, Titer, and Potency
- Improving Capsid Ratios
- Advancing Purification Techniques
- Enhancing Scale-Up
- Seamless Tech Transfer
- Enhancing Vector Optimization
… and more!

URLs:
Website: https://go.evvnt.com/2741205-0?pid=10018
Tickets: https://go.evvnt.com/2741205-2?pid=10018
Brochure: https://go.evvnt.com/2741205-3?pid=10018

Prices:
Full Conference Access - Drug Developer: USD 4197.00,
Conference + 1 Workshop - Drug Developer: USD 3598.00,
Conference Only - Drug Developer: USD 2999.00,
Full Conference Access - Academics and Research Institute: USD 3597.00,
Conference + 1 Workshop - Academic and Research Institute: USD 3098.00,
Conference Only - Academic and Research Institute: USD 2599.00,
Full Conference Access - Service Provider: USD 5097.00,
Conference + 1 Workshop - Service Provider: USD 4398.00,
Conference Only - Service Provider: USD 3699.00

Speakers: Andrew Steinsapir, Acting Chief Technology Officer, Apertura Gene Therapy, April Sena, Vice President, Technical Operations, Life Edit Therapeutics, Ashutosh Gupta, Director - Drug Substance Process Development and Manufacturing, Kiniksa Pharmaceuticals, Ishtiaq Khaliq, Gene Therapy and Molecular Biology Sciences Lead, UCB S.A., Jingying Xu, Director - Regulatory Affairs Chemistry Manufacturing and Controls, Kite, a Gilead Company, Jorge Santiago-Ortiz, Senior Director - Chemistry, Manufacturing, and Controls, Apertura Gene Therapy, Kathy Nguyen, Engineer IV, Takeda Pharmaceutical Co. Ltd, Kok Seong Lim, Analytical Sciences and Quality Control Expert, Independent Expert, Matthew Weaver, Senior Director - Chemistry, Manufacturing and Control Developability, Spirovant Sciences, Michael Datillo, Senior Investigator, Lentiviral Vector Manufacturing Excellence, Johnson and Johnson Services, Inc, Michael DiBiasio-White, Senior Scientist, Ring Therapeutics, Rekha Iyengar, Senior Scientist Upstream Vector Development, Stanford University, Tony Chikere, Director, Vector Process Development, Sangamo Therapeutics, Valerie Ng, Associate Director - Regulatory Affairs, Chemistry, Manufacturing and Controls, Kite, a Gilead Company, Ying Cai, Executive Director - Manufacturing Sciences and Technology, Ultragenyx Pharmaceutical Inc, Yuanli Song, Associate Director, Sanofi

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-5:00) Central Time (US and Canada)
09:00 AM - 05:00 PM (Feb 19, Feb 20, Feb 21) (Public)

Speakers

Andrew Steinsapir
Andrew Steinsapir
Acting Chief Technology Officer, Apertura Gene Therapy
April Sena
April Sena
Vice President, Technical Operations, Life Edit Therapeutics
Ashutosh Gupta
Ashutosh Gupta
Director - Drug Substance Process Development and Manufacturing, Kiniksa Pharmaceuticals
Ishtiaq Khaliq
Ishtiaq Khaliq
Gene Therapy and Molecular Biology Sciences Lead, UCB S.A.

Comments on 3rd Viral Vector Process Development and Manufacturing Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Hilton Boston Back Bay
40, Dalton Street, Back Bay, Boston ,
Boston 02115, Massachusetts, United States
Official Link :

More Events By Organizer

2nd Covalent Drug Discovery and Development Summit
2nd Covalent Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
Personalized Cancer Vaccine Summit
Personalized Cancer Vaccine Summit
03
Dec
2024
Free
Conferences
Cell and Gene Therapy Medical Affairs Summit
Cell and Gene Therapy Medical Affairs Summit
03
Dec
2024
Free
Conferences
Patient Recruitment for Rare Disease Trials Summit 2024
Patient Recruitment for Rare Disease Trials Summit 2024
10
Dec
2024
Free
Conferences
GPCRs-Targeted Drug Discovery Summit Europe
GPCRs-Targeted Drug Discovery Summit Europe
26
Nov
2024

GPCRs-Targeted Drug Discovery Summit Europe

Greater London, United Kingdom
Free
Conferences
Portfolio Strategy and Decision Making for Biopharma Summit 2024
Portfolio Strategy and Decision Making for Biopharma Summit 2024
21
Nov
2024

Similar Events

International Automotive Manufacturing Summit
International Automotive Manufacturing Summit
24
Jun
2023
Free
Conferences
21st Edition Of Manufacturing IT summit Indonesia | Physical Event
21st Edition Of Manufacturing IT summit Indonesia | Physical Event
15
Feb
2023
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People